Literature DB >> 33338213

Cruciferous vegetables: rationale for exploring potential salutary effects of sulforaphane-rich foods in patients with chronic kidney disease.

Ludmila F M F Cardozo1, Livia A Alvarenga1, Marcia Ribeiro1, Lu Dai1, Paul G Shiels1, Peter Stenvinkel1, Bengt Lindholm1, Denise Mafra1.   

Abstract

Sulforaphane (SFN) is a sulfur-containing isothiocyanate found in cruciferous vegetables (Brassicaceae) and a well-known activator of nuclear factor-erythroid 2-related factor 2 (Nrf2), considered a master regulator of cellular antioxidant responses. Patients with chronic diseases, such as diabetes, cardiovascular disease, cancer, and chronic kidney disease (CKD) present with high levels of oxidative stress and a massive inflammatory burden associated with diminished Nrf2 and elevated nuclear transcription factor-κB-κB expression. Because it is a common constituent of dietary vegetables, the salutogenic properties of sulforaphane, especially it's antioxidative and anti-inflammatory properties, have been explored as a nutritional intervention in a range of diseases of ageing, though data on CKD remain scarce. In this brief review, the effects of SFN as a senotherapeutic agent are described and a rationale is provided for studies that aim to explore the potential benefits of SFN-rich foods in patients with CKD.
© The Author(s) 2020. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  chronic kidney disease; gut microbiota; inflammation; nrf2; senescence; sulforaphane

Year:  2020        PMID: 33338213     DOI: 10.1093/nutrit/nuaa129

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  4 in total

1.  Deep Learning-Assisted Repurposing of Plant Compounds for Treating Vascular Calcification: An In Silico Study with Experimental Validation.

Authors:  Chia-Ter Chao; You-Tien Tsai; Wen-Ting Lee; Hsiang-Yuan Yeh; Chih-Kang Chiang
Journal:  Oxid Med Cell Longev       Date:  2022-01-05       Impact factor: 6.543

2.  Treatment of Human Glioblastoma U251 Cells with Sulforaphane and a Peptide Nucleic Acid (PNA) Targeting miR-15b-5p: Synergistic Effects on Induction of Apoptosis.

Authors:  Jessica Gasparello; Chiara Papi; Matteo Zurlo; Laura Gambari; Andrea Rozzi; Alex Manicardi; Roberto Corradini; Roberto Gambari; Alessia Finotti
Journal:  Molecules       Date:  2022-02-15       Impact factor: 4.411

Review 3.  Epi-Drugs in Heart Failure.

Authors:  Era Gorica; Shafeeq A Mohammed; Samuele Ambrosini; Vincenzo Calderone; Sarah Costantino; Francesco Paneni
Journal:  Front Cardiovasc Med       Date:  2022-07-13

Review 4.  Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives.

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Madalina Ioana Anton; Mariana Floria; Petronela Nicoleta Seritean Isac; Loredana Liliana Hurjui; Claudia Cristina Tarniceriu; Claudia Florida Costea; Manuela Ciocoiu; Ciprian Rezus
Journal:  Biomolecules       Date:  2022-09-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.